Chapter 3 Life Span Pharmacology Review

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/47

flashcard set

Earn XP

Description and Tags

A set of vocabulary-style flashcards covering lifespan pharmacology concepts from the provided notes, including pregnancy, pediatric, and older adult considerations, dosing, Beers Criteria, and nursing process implications.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

48 Terms

1
New cards

Pharmacokinetics Across the Lifespan

How absorption, distribution, metabolism, and excretion of drugs change as the body ages from infancy to old age.

2
New cards

Highest-Risk Age Groups for Drug Toxicity

Pediatric and older adult patients have the greatest risk for adverse effects and toxicity.

3
New cards

Most Drug Studies Population

Most studies are conducted in adults 13–65; pediatric use is often off-label with doses drawn from reference books.

4
New cards

Drug therapy during pregnancy

Fetus exposed to drugs mother takes.

5
New cards

Placental Transfer

Transfer of drugs from mother to fetus, occurring mainly by diffusion.

6
New cards

Drug Properties risks during pregnancy

chemistry (MW, lipid solubility, protein binding, structure), dose, duration, concurrent meds.

7
New cards

Gestational Age - First Trimester Risk

Greatest risk for birth defects due to rapid organogenesis.

8
New cards

Gestational Age - Third Trimester Risk

Highest percentage of maternal drug reaching the fetus because of increased blood flow and surface area and more free drug.

9
New cards

Maternal Factors Increasing Fetal Drug Exposure

Altered kidney/liver function and pharmacogenomics can raise fetal exposure to drugs.

10
New cards

FDA Pregnancy Classifications (A–X)

Traditional categories describing fetal risk: A, B, C, D, X.

11
New cards

FDA Category A

No risk to humans.

12
New cards

FDA Category B

No risk in animals; no human data.

13
New cards

FDA Category C

Adverse effects in animals; no human data.

14
New cards

FDA Category D

Possible risk in humans; benefits may outweigh risks.

15
New cards

FDA Category X

Fetal abnormalities—never use.

16
New cards

New Labeling System (2015+) Components

Label sections include Pregnancy, Lactation, and Females & Males of Reproductive Potential.

17
New cards

Impact of New Labeling System on Practice

Old A–X categories are still in use during transition; new sections guide prescribing decisions.

18
New cards

Drug Therapy During Breastfeeding

Many drugs pass into breast milk; risk is higher with fat-soluble, low molecular weight, high-concentration drugs; milk levels are usually lower than maternal blood levels.

19
New cards

Pediatric Definitions - Preterm

Preterm/premature: <38 weeks gestation.

20
New cards

Pediatric Definitions - Neonate

Birth to 1 month.

21
New cards

Pediatric Definitions - Infant

1 month to 1 year.

22
New cards

Pediatric Definitions - Child

1 year to 12 years.

23
New cards

Pediatric Absorption Factors

Less acidic gastric pH until 1–2 years; slowed gastric emptying; reduced first-pass metabolism; IM absorption faster and irregular.

24
New cards

Pediatric Distribution Factors

↑ total body water and ↑ fat stores; ↓ protein binding; immature BBB increases drug entry to the brain.

25
New cards

Pediatric Metabolism Factors

Immature liver with reduced microsomal enzymes.

Older kids may metabolize faster, need increased dose

26
New cards

Pediatric Excretion Factors

↓ GFR and tubular secretion; decreased renal perfusion leading to slower excretion.

27
New cards

Other Pediatric Risks

Thin skin (increased absorption potential), weak lung barriers, and poor temperature regulation leading to dehydration.

28
New cards

Dosage Calculations

Always use kg, not ins (1kg=2.2lb)

mg/kg/day or mg/kg/dose (watch carefully)

Safe range = min-max daily dose x kg

if dose outside safe range, do not give, clarify order .

Most common error: Pounds vs. Kilograms

29
New cards

Administration Considerations- Infants

Comfort (swaddling, Pacifier)

30
New cards

Administration Considerations - Toddlers

brief explanations, allow aggression within limits, comfort after.

31
New cards

Administration Considerations- Preschooler

short explanation, comfort, use magical thinking.

32
New cards

Administration Considerations- School Age

explain fully, therapeutic play, allow control.

33
New cards

Administration Considerations- Adolescents

Prepare in advance, respect privacy, encourage participation

34
New cards

Older Adult Defined

Individuals aged 65 years or older.

largest med-using population

increase chronic disease, Polypharmacy, noncompliance

35
New cards

Older Adult Pharmacokinetics - Absorption

↑ gastric pH, ↓ motility, ↓ blood flow, and ↓ surface area affect drug absorption.

36
New cards

Older Adult Pharmacokinetics - Distribution

↓ total body water → ↑ serum concentration of water-soluble drugs.

↑ fat → prolonged effects of fat-soluble drugs.

↓ albumin → ↑ free drug

37
New cards

Older Adult Pharmacokinetics - Metabolism

↓ liver enzyme activity and hepatic blood flow; prolonged half-life increases toxicity risk.

38
New cards

Older Adult Pharmacokinetics - Excretion

↓ renal blood flow, GFR, and nephron number; drugs cleared less effectively.

39
New cards

Problematic Medications in Older Adults

Analgesics (opioids, NSAIDs), Anticoagulants, Anticholinergics, Antihypertensives, Sedatives/Hypnotics/CNS depressants, Tricyclic antidepressants, Muscle relaxants.

40
New cards

Polypharmacy

Increase drug interactions

41
New cards

Beers Criteria (2019)

A list of drugs unsafe or to be used with caution in older adults.

42
New cards

Prescribing Cascade

One drug is prescribed to treat the side effects of another drug.

43
New cards

Start Low, Go Slow

Dosing principle to minimize toxicity in older adults.

44
New cards

Nonadherence in Older Adults

Common due to financial, sensory, cognitive, and manual dexterity issues.

45
New cards

Nursing Process Across Lifespan

  • Assessment: age, allergies, diet, sensory/cognitive deficits, organ function, med list, resources, support.

  • Planning: human needs statements (nutrition, perception, safety).

  • Implementation: Nine Rights, teaching, safe handling. Pediatric—disguise taste, avoid calling meds “candy.” Older adults—written large-print instructions, monitor polypharmacy.

  • Evaluation: monitor therapeutic vs. adverse effects, adjust as needed

46
New cards

Pediatric Taste-Masking in Administration

Disguise medication taste to improve acceptance in children.

47
New cards

Older Adults - Communication and Polypharmacy

Provide large-print instructions and monitor polypharmacy to reduce errors.

48
New cards

Key Exam Points for Lifespan Pharmacology

Differentiate pediatric vs. older adult pharmacokinetics; memorize labeling systems; calculate safe pediatric doses (mg/kg); recognize Beers Criteria and polypharmacy; apply Nine Rights across the lifespan.